Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/iTeos Therapeutics, Inc./ 10-K

Annual Report · 10-K

iTeos Therapeutics, Inc.

Annual Report

Filed Mar 23, 2022Accepted Mar 23, 2022, 12:11 PM EDTCIK 1808865Accession 0000950170-22-004409
View company →Permanent SEC source ↗
Share

Recent company filings

  1. SCHEDULE 13G/A - filed by Ridgeback Capital Investments L.P. regarding iTeos Therapeutics, Inc.Nov 14, 2025
  2. 15-12G filingSep 8, 2025
  3. EFFECT filingSep 4, 2025
  4. SCHEDULE 13D/A - filed by TANG CAPITAL MANAGEMENT LLC regarding iTeos Therapeutics, Inc.Sep 3, 2025
  5. 4 filingAug 29, 2025

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗